Mark Suddreth, PharmD; PGY1 Pharmacy Resident, SRHS
ACPE UAN 0062-9999-24-084-L07-T, 1.0 contact hours, knowledge-based activity
- Summarize the major changes regarding the USP compounding chapters
- Discuss the implementation of the revised USP <797> requirements on an inpatient pharmacy
- Define the roles of compounding personnel as it relates to compliance with USP <797>
Jared Cvetko, PharmD; PGY1 Pharmacy Resident, SRHS
ACPE UAN 0062-9999-24-085-L05-T, 1.0 contact hours, application-based activity
- Discuss anti-infective therapies used for multi-drug resistant pathogens
- Identify the potential for medication errors with anti-infective therapies
- Demonstrate the correct preparation of antibiotic lock therapy
Katelyn Carswell, PharmD; PGY1 Pharmacy Resident, SRHS
ACPE UAN 0062-9999-24-086-L06-T, 1.0 contact hours, knowledge-based activity
- Identify updates to the child, adolescent, and adult vaccine recommendations from the 2024 CDC schedule
- Review proper storage, handling, and administration of vaccines
- Recognize vaccine-related adverse reactions
- Discuss how to use the Vaccine Adverse Events Reporting System (VAERS)
Tim Gentilcore, PharmD; Manager - Retail Pharmacy, SRHS
ACPE UAN 0062-9999-24-087-L04-T, 1.0 contact hours, knowledge-based activity
- Discuss the differences in pharmaceutical pricing from wholesalers and manufacturers
- Identify third-party payer pharmacy reimbursements
Yin Wong, PharmD, BCACP; Clinical Discharge Pharmacist – Outpatient Pharmacy, SRHS
ACPE UAN 0062-9999-24-088-L05-T, 1.0 contact hours, application-based activity
- Explain the intent of Beers Criteria and its target audience
- Describe the major modifications made to 2023 update
- Apply the criteria to a patient case in the outpatient pharmacy setting
Erin Zee, PharmD; Clinical Discharge Pharmacist – Outpatient Pharmacy, SRHS
ACPE UAN 0062-9999-24-089-L01-T, 1.0 contact hours, application-based activity
- Review relevant changes to the 2024 ADA Guidelines
- Apply guideline recommendations to a patient case
- Summarize current oral and injectable diabetes medications on the market
- Compare and contrast biosimilar and interchangeable insulins
- Calculate insulin day supply based on patient case
Date: May 16, 2024 08:00 AM - 03:30 PM
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacy Technicians
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
- Summarize the major changes regarding the USP compounding chapters
- Discuss the implementation of the revised USP <797> requirements on an inpatient pharmacy
- Define the roles of compounding personnel as it relates to compliance with USP <797>
Speaker(s)/Author(s)
Mark Suddreth, PharmD
|
Activity Number
0062-9999-24-084-L07-TCE Hours
- Discuss anti-infective therapies used for multi-drug resistant pathogens
- Identify the potential for medication errors with anti-infective therapies
- Demonstrate the correct preparation of antibiotic lock therapy
Speaker(s)/Author(s)
Jared Cvetko, PharmD
|
Activity Number
0062-9999-24-085-L05-TCE Hours
- Identify updates to the child, adolescent, and adult vaccine recommendations from the 2024 CDC schedule
- Review proper storage, handling, and administration of vaccines
- Recognize vaccine-related adverse reactions
- Discuss how to use the Vaccine Adverse Events Reporting System (VAERS)
Speaker(s)/Author(s)
Katelyn Carswell, PharmD
|
Activity Number
0062-9999-24-086-L06-TCE Hours
- Discuss the differences in pharmaceutical pricing from wholesalers and manufacturers
- Identify third-party payer pharmacy reimbursements
Speaker(s)/Author(s)
Tim Gentilcore, PharmD
|
Activity Number
0062-9999-24-087-L04-TCE Hours
- Explain the intent of Beers Criteria and its target audience
- Describe the major modifications made to 2023 update
- Apply the criteria to a patient case in the outpatient pharmacy setting
Speaker(s)/Author(s)
Yin Wong, PharmD, BCACP
|
Activity Number
0062-9999-24-088-L05-TCE Hours
- Review relevant changes to the 2024 ADA Guidelines
- Apply guideline recommendations to a patient case
- Summarize current oral and injectable diabetes medications on the market
- Compare and contrast biosimilar and interchangeable insulins
- Calculate insulin day supply based on patient case
Speaker(s)/Author(s)
Erin Zee, PharmD
|